Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#18-1176 Listing of Knock out warrants issued by Vontobel Financial Products GmbH

As from July 10, 2018, 3 Knock out warrants issued by Vontobel Financial Products GmbH will be listed on ETP Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy.Issuer: Vontobel Financial Products GmbH Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from July 10, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: DAX 30 Index ICE Brent Crude Oil Futures Current values of strike and barrier can be found at:

#18-1175 Listing of Mini futures issued by Vontobel Financial Products GmbH

As from July 10, 2018, 2 Mini futures issued by Vontobel Financial Products GmbH will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Vontobel Financial Products GmbH Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from July 10, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: Vestas Wind Systems A/S OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data

Summer greetings from RhoVac

In 2015, RhoVac AB ("RhoVac") launched a focused three-year plan aimed at developing the company's drug candidate RV001, an immuno-oncology treatment, with the potential to prevent or limit the spread of cancer (metastasis). The current treatments (surgery, radiation and / or chemotherapy) of the mother tumor are relatively effective, but many of the patients experience serious side effects and the disease has a high risk of relapse. RhoVac’s focus is on preventing this relapse for which, the company is investing in the development of the drug candidate RV001. Today, three years later, we

Eltel divests rail operations in Norway

Eltel has today signed an agreement to divest its Norwegian rail operations to Æra AS, a wholly owned subsidiary of Jotunfjell Partners AS.Eltel's rail operations in the Norwegian market generated net sales of EUR 13.1 million in 2017 and an EBITA of EUR -4.7 million. The transaction price is EUR 1. The expected cash flow effect is EUR -0.7 million, expected to occur in the third quarter of 2018 in connection with the completion of the transaction. The sale means that the divestments of all non-core businesses, except for completion of certain projects and warranty undertakings in the

IES acquires the remaining 50% of the shares of Spanish holding company International Education Partnership, S.L.

Internationella Engelska Skolan i Sverige Holdings II AB (”Internationella Engelska Skolan” or ”IES”) has acquired the remaining 50% of the shares of joint venture International Education Partnership, S.L (”IEP”), which was incorporated in May 2018. The seller is IES’s collaborative partner in Spain, the Monzonis family. Until the transaction, IEP was held 50:50 by IES and the Monzonis family. After the acquisition, IES holds 100% of the shares of IEP, and accordingly, IEP’s accounts will be consolidated into the IES group effective July 2018. The expected purchase consideration for the

Lindab International AB (publ): Lindab's Interim Report for the second quarter 2018 to be published on 19 July 2018

The Interim Report for the second quarter 2018 will be published 07:40 am (CEST) on 19 July 2018. · A live audiocast  will be held at 10:00 am (CEST). The Interim Report will be presented by Ola Ringdahl, President and CEO, and Kristian Ackeby, CFO. · To access the audiocast, please call the Swedish number +46 (0) 8 566 427 00 ahead of the scheduled start. Alternatively, call +44 203 008 9813. · The audiocast and presentation can be followed live via the online link , or via Lindab's

#18-1174 Listing of instrument issued by BNP Paribas Issuance B.V.

As from July 12, 2018, 1 instrument issued by BNP Paribas Issuance B.V. will be listed on NDX Structured Products Finland. The instrument will be registered at Euroclear Finland Oy.Issuer: BNP Paribas Issuance B.V. Agent: SIP Nordic For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned

Heliospectra Features HelioCORE™ Light Control System and New Series of Lightbars at Cultivate’18 in Columbus, Ohio

Greenbelt Microgreens and Commerical Food Growers Achieve Consistent Production Cycles with Heliospectra's New LED Lighting Solutions GOTHENBURG, Sweden / SAN FRANCISCO, CA, 9 July 2018 Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, will showcase the company’s new vertical farming lightbar solution and the recently released HelioCORE™ light control software  at Cultivate’18 in booth #3154 

OptiFreeze signs a Letter of Intent with one of the largest Distributors of dried herbs and spices

OptiFreeze signed a letter of intent on the 5thof July with one of the largest Distributorsof dried herbs and spices in Europe. The intention is to introduce the OptiFreeze technology and to sell the OptiCeptTMprocessing systems to the Distributor’s suppliers. According to the agreement, the Distributor will have a limited exclusive right for several herbs forthe Nordic, Benelux, Baltic states and UK market for a limited period of time. The Distributor has an interest to provide high quality premium products to the market. Both the Distributor and OptiFreeze are motivatedand understand

Panion Animal Health AB (Publ):First trading day for series 2019 warrants

Panion Animal Health AB today announced that the first trading day of warrants of series 2019 will be July 12, 2018. One (1) warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 1.31 per share. Subscription of shares under the warrants shall be in accordance with the terms of the warrants during the period from September 1, 2019 through September 30, 2019. Shares and share capitalThe preferential share issue of units has been partly registered at the Swedish Companies Registration Office and the total number of shares amounts to

LUNDIN GOLD CLOSES US$350 MILLION SENIOR DEBT FACILITY AND ANNOUNCES OFFTAKE AGREEMENT

VANCOUVER, CANADA, July 9, 2018 /CNW/ - Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) is pleased to announce that it has closed its previously announced senior secured project finance debt facility of $350 million (the “Facility”) with a syndicate of seven senior lenders to fund the development and construction of the Fruta del Norte gold project in Ecuador (“Fruta del Norte” or the “Project”). The Company has also executed a gold concentrate offtake agreement (the “Offtake”). All amounts in this release are in U.S. dollars unless otherwise indicated.

New Distributor Pedab Grows Clavister Channel Business in Northern Europe

One of the Nordics largest distributors adds Clavister to their vendor portfolio to enable secure business continuity to organizations throughout Scandinavia, Baltics and France. Distributing Clavister and using the technology will drive revenue growth and deepen market share.Örnsköldsvik, Sweden. 2018-07-09. Clavister, a leader in high-performance cybersecurity security solutions, today welcomes its newest distributor, Nordics based Pedab, who will begin offering Clavister to their extensive reselling network and as integrated technology in the Pedab Managed Security Services. Pedab is

Quarterly report Q2, 2018

Visma had another strong quarter with excellent top-line revenue and continued profit growth. Total revenue growth was 26.1% while EBITDA grew strongly as well by 23.5% over Q2 2017 to reach NOK 577 million. Download Q2 report  Revenues in each of Visma's four largest divisions (representing over 98% of EBITDA) grew well in excess of 20% year-on-year. The SMB Division grew revenues by 21%, Enterprise grew by an impressive 42%, Custom Solutions achieved 39% growth, and Commerce Solutions grew 25%

Presentation of Intrum’s results for January-June 2018

Intrum announces its’ interim results for January-June 2018 on 24 July 2018 at 7:00 a.m. CET. The report will be presented in a live webcast at 9:00 a.m. CET the same dayMikael Ericson, President & CEO and Thomas Moss, acting CFO, will present the results and answer questions. The conference will be held in English.To listen in to the conference live, please dial: +44 20 3008 9817 (UK)+46 8 5063 9549 (SE)+1 855 831 5947 (US) Link to live video cast  Link to video cast is also available on www.intrum.com. Participants are advised

Intervacc signs an agreement for future filling and release of Strangvac.

Strangvac is Intervacc's vaccine against strangles, which is a very severe and contagious infection in the horse. Intervacc has previously signed an agreement with 3P Biopharmaceuticals in Pamplona, Spain for large-scale commercial production of the components in Strangvac. The now signed agreement with Praxis Pharmaceuticals in Spain means that they will provide final formulation, filling of vials and packaging and final release of finished product. "With this agreement, we have been assured that the entire manufacturing chain is in place for commercial production of Strangvac. We look

HUNTER GROUP ASA: RESULT OF THE SUBSEQUENT OFFERING

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT.Oslo, July 9, 2018 Reference is made to the previous announcements by Hunter Group ASA (the “Company” or “Hunter”) relating to the subsequent offering of up to 16,250,000 new shares (the “Offer Shares”) for gross proceeds of up to NOK 52,000,000 (the “

Tecnotree announces rapid service creation initiative with a key operator in Iran

Tecnotree CorporationStock Exchange Release9 July 2018 at 13.30 EESTTecnotree announces rapid service creation initiative with a key operator in Iran Tecnotree has been selected by a key operator in Iran to accelerate time to market and agile responses to the market needs in their service creation and revenue generation capabilities by establishing a team of experts in collaboration with Tecnotree. The deal is significant to Tecnotree, as it is valued at USD 1.9 million and strengthens the well-established relationship with the company’s key customer in Iran. The customer has been

Camanio Care signs a new distributor for Bestic in Hong Kong

Camanio Care has signed a contract with Kerry Medical Ltd. for distribution of the assistive eating device Bestic. The contract is exclusive, which means that Kerry Medical becomes Camanio Cares exclusive distributor in Hong Kong.Hong Kong is potentially large market for Camanio Care’s eating assistive device Bestic. More than 16% of Hong Kong's population is over 65 years today, and it is estimated that doubling share to 2036. -       The agreement with Kerry Medical is strategic and completely in line with our ambitions in Hong Kong. We are very excited to become partner with such an

Ayima June 2018 Interim Sales Report

Ayima’s preliminary sales figure for the month of June 2018 is 14.2MSEK, a 37.5% increase from the same period in 2017 (10.4MSEK).Ayima continues to grow organically to plan and continues to invest in business development and marketing in order to have a strong sales pipeline to continue this trend. For further Information: CEO/VD Michael Jacobson +44-20 7148 5974 press(at)ayima.com www.ayima.com @AyimaGroupAbout Ayima Originally founded in 2007, Ayima is a digital marketing agency with around 145 employees across its offices in London, Stockholm, New York, San Francisco and

Chief Medical Officer appointed for clinical trials of world’s first therapy targeting both PMDD and menstrual migraine

Stockholm – June 29, 2018. A small Swedish pharmaceutical company has taken another step towards being the first company in the world to launch a targeted treatment for PMDD—the most debilitating form of PMS. Dr Märta Segerdahl has been appointed Chief Medical Officer, with over 20 years’ experience in pain medicine, including menstrual migraine.“There are very few drugs out there for the worst type of PMS,” says new Asarina Pharma CMO Märta Segerdahl. “And the ones we have are only moderately effective for some patients. I’ve been in this field for years, very few companies have come as

Multiconsult to deliver consultancy services in a significant contract for E6 between Ranheim and Værnes

Nye Veier has chosen Acciona Construccion S.A, Leonard Nilsen & Sønner, Acciona Mantenimiento de infrastructuras S.A. and Multiconsult for the EPC contract of approximately NOK 4 billion, developing and constructing the E6 between Ranheim and Værnes. The project is loacated in the municipalities Trondheim, Malvik and Stjørdal in Norway, and Multiconsult is to deliver all engineering services. The contract value for Multiconsult is significant, but still under negotiation.The contract is now in the clarification phase and will be signed in the end of September 2018. After approximately one

Transas to promote fleet efficiency for Wilson Ship Management

Wärtsilä Corporation, Press release, 9 July 2018 at 12.00 noon EESTTransas, a Wärtsilä company, has signed a landmark contract to supply a Fleet Operations Solution (FOS) to Wilson ASA, the Norway-based fleet operator. The FOS creates an infrastructure that includes onboard navigational and communication components to provide enhanced connectivity for business communications and crew services, and access to fleet data from shore-based locations for complete situational awareness. The order was booked in Q1, 2018.This will be one of the first applications of the Thesis concept within

Invitation to presentation of Bravida’s report for the second quarter 2018 on the 20th of July

Bravida’s report for the second quarter 2018 will be published 07:30 CET on the 20th of July.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Nils-Johan Andersson. The presentation will be held in English and can be followed on the web or over the phone. There will be room for questions. Link to the webcast:https://tv.streamfabriken.com/bravida-q2-2018 Telephone numbers for telephone conference:SE: +46 8 5664 27 01UK: +44 20 3008 9810US: +1 85 5831 5945 The report and the presentation will be available on www.bravida.se/en/

Redwood Pharma has submitted an application for the start of clinical trial

Redwood Pharma has submitted its first national clinical trial application for the start of the RP101 trial. This application represents a significant milestone in the development of the Company’s novel treatment for chronic dry eye disease (DED) in postmenopausal women.“It is with satisfaction that we can announce that our first clinical trial application has been submitted to a national authority and ethical committee. The start of the clinical trial is planned for Q3 assuming required approvals have been granted. After completion of the toxicology studies at the end of 2017 and a

There are no items matching the current filter
There are no more items matching the current filter
Back to top